A Study of Two Different Formulations of LY3209590 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

September 3, 2021

Study Completion Date

September 3, 2021

Conditions

Healthy

Interventions

DRUG

LY3209590

Administered SC.

Trial Locations (1)

Covance Clinical Research, Leeds

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT04768842 - A Study of Two Different Formulations of LY3209590 in Healthy Participants | Biotech Hunter | Biotech Hunter